Selected research
Market Outlook & Growth Opportunities
Global Custom Gene Synthesis Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Custom Gene Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Custom Gene Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom Gene Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Custom Gene Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Custom Gene Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Custom Gene Synthesis Service market include Genescript, Thermo Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Azenta Life Sciences, SBS Genetech and Bio Basic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Custom Gene Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom Gene Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Gene Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Gene Synthesis Service market.
Custom Gene Synthesis Service Segment by Company
Genescript
Thermo Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Custom Gene Synthesis Service Segment by Type
Below 1000 bp
1001 to 3000 bp
3001 to 5000 bp
Above 5000 bp
Custom Gene Synthesis Service Segment by Application
Commercial
Academic Research
Custom Gene Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Gene Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Gene Synthesis Service key companies, revenue, market share, and recent developments.
3. To split the Custom Gene Synthesis Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Gene Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Gene Synthesis Service significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Gene Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Gene Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Gene Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Gene Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Gene Synthesis Service industry.
Chapter 3: Detailed analysis of Custom Gene Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Gene Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Gene Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 1000 bp
- 1001 to 3000 bp
- 3001 to 5000 bp
- Above 5000 bp
Applications
- Commercial
- Academic Research
Companies covered
- Genescript
- Thermo Scientific
- IDT
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Azenta Life Sciences
- SBS Genetech
- Bio Basic
- Twist Bioscience
- OriGene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Custom Gene Synthesis Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Custom Gene Synthesis Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Gene Synthesis Service Market Dynamics
- 2.1 Custom Gene Synthesis Service Industry Trends
- 2.2 Custom Gene Synthesis Service Industry Drivers
- 2.3 Custom Gene Synthesis Service Industry Opportunities and Challenges
- 2.4 Custom Gene Synthesis Service Industry Restraints
3 Custom Gene Synthesis Service Market by Company
- 3.1 Global Custom Gene Synthesis Service Company Revenue Ranking in 2025
- 3.2 Global Custom Gene Synthesis Service Revenue by Company (2021-2026)
- 3.3 Global Custom Gene Synthesis Service Company Ranking (2024-2026)
- 3.4 Global Custom Gene Synthesis Service Company Manufacturing Base and Headquarters
- 3.5 Global Custom Gene Synthesis Service Company Product Type and Application
- 3.6 Global Custom Gene Synthesis Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Custom Gene Synthesis Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Custom Gene Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Custom Gene Synthesis Service Market by Type
- 4.1 Custom Gene Synthesis Service Type Introduction
- 4.1.1 Below 1000 bp
- 4.1.2 1001 to 3000 bp
- 4.1.3 3001 to 5000 bp
- 4.1.4 Above 5000 bp
- 4.2 Global Custom Gene Synthesis Service Sales Value by Type
- 4.2.1 Global Custom Gene Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Custom Gene Synthesis Service Sales Value by Type (2021-2032)
- 4.2.3 Global Custom Gene Synthesis Service Sales Value Share by Type (2021-2032)
5 Custom Gene Synthesis Service Market by Application
- 5.1 Custom Gene Synthesis Service Application Introduction
- 5.1.1 Commercial
- 5.1.2 Academic Research
- 5.2 Global Custom Gene Synthesis Service Sales Value by Application
- 5.2.1 Global Custom Gene Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Custom Gene Synthesis Service Sales Value by Application (2021-2032)
- 5.2.3 Global Custom Gene Synthesis Service Sales Value Share by Application (2021-2032)
6 Custom Gene Synthesis Service Regional Value Analysis
- 6.1 Global Custom Gene Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Custom Gene Synthesis Service Sales Value by Region (2021-2032)
- 6.2.1 Global Custom Gene Synthesis Service Sales Value by Region: 2021-2026
- 6.2.2 Global Custom Gene Synthesis Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Custom Gene Synthesis Service Sales Value (2021-2032)
- 6.3.2 North America Custom Gene Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Custom Gene Synthesis Service Sales Value (2021-2032)
- 6.4.2 Europe Custom Gene Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Custom Gene Synthesis Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Custom Gene Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Custom Gene Synthesis Service Sales Value (2021-2032)
- 6.6.2 South America Custom Gene Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Custom Gene Synthesis Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Custom Gene Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 Custom Gene Synthesis Service Country-level Value Analysis
- 7.1 Global Custom Gene Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Custom Gene Synthesis Service Sales Value by Country (2021-2032)
- 7.2.1 Global Custom Gene Synthesis Service Sales Value by Country (2021-2026)
- 7.2.2 Global Custom Gene Synthesis Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Custom Gene Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Custom Gene Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Custom Gene Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Genescript
- 8.1.1 Genescript Company Information
- 8.1.2 Genescript Business Overview
- 8.1.3 Genescript Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Genescript Custom Gene Synthesis Service Product Portfolio
- 8.1.5 Genescript Recent Developments
- 8.2 Thermo Scientific
- 8.2.1 Thermo Scientific Company Information
- 8.2.2 Thermo Scientific Business Overview
- 8.2.3 Thermo Scientific Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Scientific Custom Gene Synthesis Service Product Portfolio
- 8.2.5 Thermo Scientific Recent Developments
- 8.3 IDT
- 8.3.1 IDT Company Information
- 8.3.2 IDT Business Overview
- 8.3.3 IDT Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.3.4 IDT Custom Gene Synthesis Service Product Portfolio
- 8.3.5 IDT Recent Developments
- 8.4 Eurofins Genomics
- 8.4.1 Eurofins Genomics Company Information
- 8.4.2 Eurofins Genomics Business Overview
- 8.4.3 Eurofins Genomics Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Eurofins Genomics Custom Gene Synthesis Service Product Portfolio
- 8.4.5 Eurofins Genomics Recent Developments
- 8.5 DNA 2.0 (ATUM)
- 8.5.1 DNA 2.0 (ATUM) Company Information
- 8.5.2 DNA 2.0 (ATUM) Business Overview
- 8.5.3 DNA 2.0 (ATUM) Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.5.4 DNA 2.0 (ATUM) Custom Gene Synthesis Service Product Portfolio
- 8.5.5 DNA 2.0 (ATUM) Recent Developments
- 8.6 BBI
- 8.6.1 BBI Company Information
- 8.6.2 BBI Business Overview
- 8.6.3 BBI Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.6.4 BBI Custom Gene Synthesis Service Product Portfolio
- 8.6.5 BBI Recent Developments
- 8.7 Azenta Life Sciences
- 8.7.1 Azenta Life Sciences Company Information
- 8.7.2 Azenta Life Sciences Business Overview
- 8.7.3 Azenta Life Sciences Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Azenta Life Sciences Custom Gene Synthesis Service Product Portfolio
- 8.7.5 Azenta Life Sciences Recent Developments
- 8.8 SBS Genetech
- 8.8.1 SBS Genetech Company Information
- 8.8.2 SBS Genetech Business Overview
- 8.8.3 SBS Genetech Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.8.4 SBS Genetech Custom Gene Synthesis Service Product Portfolio
- 8.8.5 SBS Genetech Recent Developments
- 8.9 Bio Basic
- 8.9.1 Bio Basic Company Information
- 8.9.2 Bio Basic Business Overview
- 8.9.3 Bio Basic Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Bio Basic Custom Gene Synthesis Service Product Portfolio
- 8.9.5 Bio Basic Recent Developments
- 8.10 Twist Bioscience
- 8.10.1 Twist Bioscience Company Information
- 8.10.2 Twist Bioscience Business Overview
- 8.10.3 Twist Bioscience Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Twist Bioscience Custom Gene Synthesis Service Product Portfolio
- 8.10.5 Twist Bioscience Recent Developments
- 8.11 OriGene
- 8.11.1 OriGene Company Information
- 8.11.2 OriGene Business Overview
- 8.11.3 OriGene Custom Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.11.4 OriGene Custom Gene Synthesis Service Product Portfolio
- 8.11.5 OriGene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst